Asia Pacific Drug Delivery Systems Market to Reach US$ 441,337.0 Mn at a CAGR of 8.6% in 2027 | The Insight Partners

Asia Pacific Drug Delivery Systems Market to 2027 - Regional Analysis and Forecasts by Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country

Publication Month: Oct 2019 | Report Code: TIPRE00007130 | No. of Pages: 261 | Category: Medical Device | Status: Published

The Asia Pacific drug delivery systems market is expected to reach US$ 441,337.0 Mn in 2027 from US$ 212,012.7 Mn in 2018. The market is estimated to grow with a CAGR of 8.6% from 2019-2027.

 

The growth of the market is driven by the factors such as, rapid technological advancements in diabetes care devices and increasing rate of obesity. However, the market is likely to slower down its growth due to the increasing reuse of pen needles in the region.

 

Obesity is one of the major problem and the biggest concern in all the countries across the region. Currently, more than one in two adults and nearly one in six children are obese. Obesity is one of the major issues that affects people of all ages and incomes globally. Overweight and obesity is the abnormal or excessive fat accumulation in the body leading to impaired health. According to the MoHFW, Government of India, in India is approx. 60 million adults with diabetes (7.8% of the population), of which more than 30 million are undiagnosed or untreated anticipated in 2015. Thus, there is higher increasing risk of developing complications and premature mortality. Obesity plays a major role in increasing diabetes among the population across the region. Physical activity is important to maintain the blood glucose level. Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of obesity and diabetes, cardiovascular disease (CVD), chronic respiratory illnesses, and diet-related cancers. According the data of National Health and Nutrition Examination Survey, in 2015-2016, the obesity rate between the youth of the age group between 2 to 19 is 18.5%. The rate varies among different age groups, with rates rising along with age. While overall obesity rates remain higher than they were a generation ago.

Lack of exercise, unhealthy diet, and rapid growth in the obese population is expected to increase the susceptibility of diabetes among population in the region.

 

China is expected to lead the market in the Asia Pacific region owing to the technological advancements in medical device industry and rising focus on diagnosis and treatment of chronic diseases among the adults and the elderly population. Moreover, emergence of local players and rising number of product approvals in the country is expected to support the growth of drug delivery systems market in China. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

 

Exhibit: Rest of Asia Pacific Drug Delivery Systems Market Revenue and Forecasts to 2027 (US$ Mn)


 

 

ASIA PACIFIC DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION

By Product

  • Oral
    • Solid Oral Drugs
    • Liquid Oral Drugs
    • Semi-solid Oral Drugs
  • Transmucosal
    • Pulmonary Drug Delivery
      • In-metered Dose Inhalers
      • Dry Powder Inhalers
      • Nebulizers
    • Nasal Drug Delivery
      • Nasal Sprays
      • Nasal Drops
      • Nasal Gels
    • Buccal Drug Delivery
    • Sublingual Drug Delivery
    • Rectal Transmucosal Drug delivery
    • Vaginal Transmucosal Drug Delivery
  • Injectable
    • Conventional Injection Devices
    • Self-Injection Devices
    • Needle Free Injectors
    • Pen Injectors
    • Wearable Injectors
  • Topical
    • Semi-solid Topical Drug Delivery Formulations
    • Liquid Topical Drug Delivery Formulations
    • Solid Topical Drug Delivery Formulations
    • Transdermal Patches
    • Transdermal Gels
    • Others
  • Implantable
    • Active Implantable
    • Passive Implantable
  • Ocular
    • Eye Drops & Sprays
    • Gels & Ointments
    • Ocular Inserts
    • Drug Coated Contact Lenses

By Application

  • Hospital & Clinics
  • Home Care Settings
  • Others

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

By Geography

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia

Company Profiles

  • BD
  • 3M
  • Novo Nordisk A/S
  • BD
  • Novo Nordisk A/S
  • Boston Scientific Corporation
  • Bausch Health Companies Inc.
  • Baxter
  • Boehringer Ingelheim
  • Novartis AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.

1.              Introduction

1.1       Scope Of The Study

1.2       The Insight Partners Research Report Guidance

2.              Asia Pacific Drug Delivery Systems Market –  Key Takeaways

3.              Asia Pacific Drug Delivery Systems Market – Market Landscape

3.1       Overview

3.2       Market Segmentation

3.2.1       Asia Pacific Drug Delivery Systems Market – By Route Of Administration

3.2.2       Asia Pacific Drug Delivery Systems Market – By Application

3.2.3       Asia Pacific Drug Delivery Systems Market – By Distribution Channel

3.2.4       Asia Pacific Drug Delivery Systems Market – By Country

3.3       Pest Analysis

4.              Asia Pacific Drug Delivery Systems Market - Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Rapid Technological Advancements in Diabetes Care Devices

4.1.2       Increasing Rate of Obesity

4.2       Key Market Restraints

4.2.1       Increasing Reuse Of Pen Needles

4.3       Key Market Opportunities

4.3.1       Growing Medical Tourism In Developing Countries

4.4       Future Trends

4.4.1       Adoption Of Advanced Technology

4.5       Impact Analysis

5.              Drug Delivery Systems Market – Asia Pacific Analysis

5.1       Asia Pacific Drug Delivery Systems Market Revenue Forecasts And Analysis

5.2       Market Positioning

5.2.1       BD

5.2.2       3M

5.2.3       Glaxosmithkline Plc.

5.2.4       Novartis Ag

6.              Asia Pacific Drug Delivery Systems Market Analysis – By Route Of Administration

6.1       Overview

6.2       Asia Pacific Drug Delivery Systems Market By Route Of Administration, 2018 & 2027 (%)

6.3       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

6.3.1       Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.2       Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.3       Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.4       Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.4.1    Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.5       Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.6       Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.7       Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.3.8       Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)

6.4       Oral Drug Delivery Market

6.4.1       Overview

6.4.2       Oral Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.4.3       Solid Oral Drugs Market

6.4.3.1    Overview

6.4.3.2    Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)

6.4.3.3    Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

6.4.4       Liquid Oral Drugs Market

6.4.4.1    Overview

6.4.4.2    Liquid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)

6.4.4.3    Liquid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

6.4.5       Semi-Solid Oral Drugs Market

6.4.5.1    Overview

6.4.5.2    Semi-Solid Oral Drugs Market Revenue And Forecast To 2027 (US$ Mn)

6.4.5.3    Semi-Solid Oral Drugs Market Revenue And Forecasts To 2027 (US$ Mn)

6.5       Transmucosal Drug Delivery Market

6.5.1       Overview

6.5.2       Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.5.3       Pulmonary Drug Delivery Market

6.5.3.1    Overview

6.5.3.2    Pulmonary Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.5.3.3    Pulmonary Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

6.5.3.4    In-Metered Dose Inhalers Market

6.5.3.4.1    Overview

6.5.3.4.2    In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

6.5.3.5    Dry Powder Inhalers Market

6.5.3.5.1    Overview

6.5.3.5.2    Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

6.5.3.6    Nebulizers Market

6.5.3.6.1    Overview

6.5.3.6.2    Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)

6.5.4       Nasal Drug Delivery Market

6.5.4.1    Overview

6.5.4.2    Nasal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.5.4.3    Nasal Spray Market

6.5.4.3.1    Overview

6.5.4.3.2    Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)

6.5.4.4    Nasal Drops Market

6.5.4.4.1    Overview

6.5.4.4.2    Nasal Drops Market Revenue and Forecast to 2027 (US$ Mn)

6.5.4.5    Nasal Gel Market

6.5.4.5.1    Overview

6.5.4.5.2    Nasal Gel Market Revenue and Forecast to 2027 (US$ Mn)

6.5.5       Buccal Drug Delivery Market

6.5.5.1    Overview

6.5.5.2    Buccal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.5.6       Sublingual Drug Delivery Market

6.5.6.1    Overview

6.5.6.2    Sublingual Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.5.7       Rectal Transmucosal Drug Delivery Market

6.5.7.1    Overview

6.5.7.2    Rectal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.5.8       Vaginal Transmucosal Drug Delivery Market

6.5.8.1    Overview

6.5.8.2    Vaginal Transmucosal Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.6       Topical Drug Delivery Market

6.6.1       Overview

6.6.2       Topical Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.6.3       Semi-Solid Topical Drug Delivery Formulations Market

6.6.3.1    Overview

6.6.3.2    Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)

6.6.4       Liquid Topical Drug Delivery Formulations Market

6.6.4.1    Overview

6.6.4.2    Liquid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)

6.6.5       Solid Topical Drug Delivery Formulations Market

6.6.5.1    Overview

6.6.5.2    Solid Topical Drug Delivery Formulations Market Revenue And Forecast To 2027 (US$ Mn)

6.6.6       Transdermal Patches Market

6.6.6.1    Overview

6.6.6.2    Transdermal Patches Market Revenue And Forecast To 2027 (US$ Mn)

6.6.7       Transdermal Gels Market

6.6.7.1    Overview

6.6.7.2    Transdermal Gels Market Revenue And Forecast To 2027 (US$ Mn)

6.6.8       Others Market

6.6.8.1    Overview

6.6.8.2    Others Market Revenue And Forecast To 2027 (US$ Mn)

6.7       Injectable Drug Delivery Market

6.7.1       Overview

6.7.2       Injectable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.7.3       Conventional Injection Devices Market

6.7.3.1    Overview

6.7.3.2    Conventional Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)

6.7.4       Self-Injection Devices Market

6.7.4.1    Overview

6.7.4.2    Self-Injection Devices Market Revenue And Forecast To 2027 (US$ Mn)

6.7.4.3    Needle Free Injectors Market

6.7.4.3.1    Overview

6.7.4.3.2    Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)

6.7.4.4    Pen Injectors Market

6.7.4.4.1    Overview

6.7.4.4.2    Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)

6.7.4.5    Wearable Injectors Market

6.7.4.5.1    Overview

6.7.4.5.2    Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)

6.8       Implantable Drug Delivery Market

6.8.1       Overview

6.8.2       Implantable Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.8.3       Active Implantable Market

6.8.3.1    Overview

6.8.3.2    Active Implantable Market Revenue And Forecast To 2027 (US$ Mn)

6.8.4       Passive Implantable Market

6.8.4.1    Overview

6.8.4.2    Passive Implantable Market Revenue And Forecast To 2027 (US$ Mn)

6.9       Ocular Drug Delivery Market

6.9.1       Overview

6.9.2       Ocular Drug Delivery Market Revenue And Forecast To 2027 (US$ Mn)

6.9.3       Eye Drops And Sprays Market

6.9.3.1    Overview

6.9.3.2    Eye Drops And Sprays Market Revenue And Forecast To 2027 (US$ Mn)

6.9.4       Gels & Ointments Market

6.9.4.1    Overview

6.9.4.2    Gels & Ointments Market Revenue And Forecast To 2027 (US$ Mn)

6.9.5       Ocular Inserts Market

6.9.5.1    Overview

6.9.5.2    Ocular Inserts Market Revenue And Forecast To 2027 (US$ Mn)

6.9.6       Drug Coated Contact Lens Market

6.9.6.1    Overview

6.9.6.2    Drug Coated Contact Lens Market Revenue And Forecast To 2027 (US$ Mn)

7.              Asia Pacific Drug Delivery Systems Market Analysis – By Application

7.1       Overview

7.2       Asia Pacific Endodontic Devices Market Share By Application 2018 & 2027 (%)

7.3       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

7.4       Homecare Settings Market

7.4.1       Overview

7.4.2       Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)

7.5       Hospitals & Clinics Market

7.5.1       Overview

7.5.2       Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

7.6       Others Market

7.6.1       Overview

7.6.2       Others Market Revenue And Forecasts To 2027 (US$ Mn)

8.              Asia Pacific Drug Delivery Systems Market Analysis – By Distribution Channel

8.1       Overview

8.2       Asia Pacific Endodontic Devices Market Share By Distribution Channel 2018 & 2027 (%)

8.3       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

8.4       Homecare Settings Market

8.4.1       Overview

8.4.2       Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)

8.5       Hospital Pharmacies Market

8.5.1       Overview

8.5.2       Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

8.6       Retail Pharmacies Market

8.6.1       Overview

8.6.2       Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

8.7       Online Pharmacies Market

8.7.1       Overview

8.7.2       Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

9.              Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027

9.1       Overview

9.1.1       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)

9.1.2       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

9.1.2.1    Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.2.2    Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.2.3    Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.2.4    Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.2.4.1    Asia Pacific Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.2.5    Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.2.6    Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.2.7    Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.2.8    Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)

9.1.3       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

9.1.4       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

9.1.5       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)

9.1.6       China Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)

9.1.7       China Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)

9.1.7.1    China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

9.1.7.1.1    China Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.2    China Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.3    China Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.4    China Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.5    China Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.6    China Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.7    China Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.8    China Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.1.9    China Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.2    China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

9.1.7.3    China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

9.1.8       Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)

9.1.9       Japan Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)

9.1.9.1    Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

9.1.9.1.1    Japan Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.2    Japan Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.3    Japan Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.4    Japan Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.5    Japan Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.6    Japan Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.7    Japan Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.8    Japan Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.1.9    Japan Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.2    Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

9.1.9.3    Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

9.1.10    India Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)

9.1.11    India Drug Delivery Systems Market Revenue And Forecasts To 2027 (US$ Mn)

9.1.11.1  India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

9.1.11.1.1 India Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.2 India Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.3 India Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.4 India Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.5 India Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.6 India Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.7 India Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.8 India Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.1.9 India Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.2  India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

9.1.11.3  India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

10.           Drug Delivery Systems Market – Industry Landscape

10.1    Overview

10.2    Comparative Company Analysis

10.3    Growth Strategies done by the companies in the Market, (%)

10.4    Organic Developments

10.4.1    Overview

10.5    Inorganic developments

10.5.1    Overview

11.           Drug Delivery Systems Market–Key Company Profiles

11.1    3M

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Product Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2    BD

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Financial Overview

11.2.4    Product Portfolio

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    Boston Scientific Corporation

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Overview

11.3.4    Product Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    Novo Nordisk A/S

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Overview

11.4.4    Product Portfolio

11.4.5    SWOT Analysis

11.4.6    Key Developments

11.5    Bausch Health Companies Inc.

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Financial Overview

11.5.4    Product Portfolio

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    BAxter International, Inc.

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial Overview

11.6.4    Product Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Boehringer Ingelheim International GmbH

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Product Portfolio

11.7.5    SWOT Analysis

11.7.6    Key Developments

11.8    Novartis AG

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Information

11.8.4    Product Portfolio

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    GlaxoSmithKline plc.

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Financial Overview

11.9.4    Product Portfolio

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  Terumo Corporation

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product portfolio

11.10.5 SWOT ANALYSIS

11.10.6 KEY DEVELOPMENTS

11.11  Johnson & Johnson Services, Inc.

11.11.1 Key Facts

11.11.2 Business Description

11.11.3 Financial Overview

11.11.4 Product Portfolio

11.11.5 Swot Analysis

11.11.6 Key Developments

12.           Appendix

12.1    About The Insight Partners

12.2    Glossary Of Terms

13.          Glossary of Terms, Drug delivery systems market

13.1    Methodology

13.1.1    Coverage

13.1.2    Secondary Research

13.1.3    Primary Research


LIST OF TABLES

Table 1.            Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

Table 2.            Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 3.            Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 4.            Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 5.            Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 6.            Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 7.            Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 8.            Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 9.            Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 10.         Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 11.         Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 12.         Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 13.         Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

Table 14.         Asia Pacific Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 15.         Asia Pacific Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 16.         Asia Pacific Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 17.         Asia Pacific Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 18.         Asia Pacific Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 19.         Asia Pacific Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 20.         Asia Pacific Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 21.         Asia Pacific Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 22.         Asia Pacific Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 23.         Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 24.         Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 25.         China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

Table 26.         China Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 27.         China Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 28.         China Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 29.         China Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 30.         China Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 31.         China Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 32.         China Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 33.         China Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 34.         China Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 35.         China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 36.         China Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 37.         Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

Table 38.         Japan Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 39.         Japan Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 40.         Japan Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 41.         Japan Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 42.         Japan Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 43.         Japan Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 44.         Japan Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 45.         Japan Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 46.         Japan Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 47.         Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 48.         Japan Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 49.         India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

Table 50.         India Transmucosal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 51.         India Oral Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 52.         India Pulmonary Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 53.         India Injectable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 54.         India Self-Injection Devices Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 55.         India Topical Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 56.         India Nasal Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 57.         India Implantable Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 58.         India Ocular Market Revenue And Forecasts To 2027, By Type (US$ Mn)

Table 59.         India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Application (US$ Mn)

Table 60.         India Drug Delivery Systems Market Revenue And Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 61.         Organic Developments Done By Companies

Table 62.         Inorganic developments done by Companies


LIST OF FIGURES

Figure 1.          China Drug Delivery Systems Market, Revenue (US$ Mn), By Country 2018 & 2027

Figure 2.          Asia Pacific Drug Delivery Systems Market By Route Of Administration, Market Share (%), 2018

Figure 3.          Asia Pacific Drug Delivery Systems Market By Application, Market Share (%), 2018

Figure 4.          Asia Pacific Drug Delivery Systems Market By Distribution Channel, Market Share (%), 2018

Figure 5.          Drug Delivery Systems Market Segmentation

Figure 6.          Asia Pacific Pest Analysis

Figure 7.          Drug Delivery Systems Market Impact Analysis Of Drivers & Restraints

Figure 8.          Asia Pacific Drug Delivery Systems Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 9.          Global Drug Delivery Systems Market – Medical Device, 2017

Figure 10.       Global Drug Delivery Systems Market – Pharmaceuticals, 2017

Figure 11.       Asia Pacific Drug Delivery Systems Market, By Route Of Administration 2018 & 2027 (%)

Figure 12.       Oral Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 13.       Transmucosal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 14.       In-Metered Dose Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 15.       Dry Powder Inhalers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 16.       Nebulizers Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 17.       Nasal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 18.       Nasal Spray Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 19.       Nasal Spray Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 20.       Nasal Gel Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 21.       Buccal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 22.       Sublingual Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 23.       Rectal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 24.       Vaginal Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 25.       Topical Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 26.       Semi-Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 27.       Liquid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 28.       Solid Topical Drug Delivery Formulations Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 29.       Transdermal Patches Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 30.       Transdermal Gels Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 31.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 32.       Injectable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 33.       Conventional Injection Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 34.       Self-Injection Devices Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 35.       Needle Free Injectors Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 36.       Pen Injectors Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 37.       Wearable Injectors Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 38.       Implantable Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 39.       Active Implantable Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 40.       Passive Implantable Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 41.       Ocular Drug Delivery Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 42.       Eye Drops And Spray Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 43.       Gels & Ointments Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 44.       Ocular Inserts Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 45.       Drug Coated Contact Lens Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 46.       Asia Pacific Endodontic Device Market Share By Application 2018 & 2027 (%)

Figure 47.       Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 48.       Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 49.       Others Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 50.       Asia Pacific Endodontic Device Market Share By Distribution Channel 2018 & 2027 (%)

Figure 51.       Homecare Settings Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 52.       Hospital Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 53.       Retail Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 54.       Online Pharmacies Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 55.       Asia Pacific Drug Delivery Systems Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 56.       Asia Pacific Market Revenue And Forecasts To 2027 (US$ Mn)

Figure 57.       Asia Pacific Drug Delivery Systems Market Revenue And Forecasts To 2027, By Country (%)

Figure 58.       China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.       Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

Figure 60.       India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

Figure 61.       Comparative Company Analysis

Figure 62.       Growth Strategies done by the companies in the Market, (%)

 

The List of Companies

 

  1. BD
  2. 3M
  3. Novo Nordisk A/S
  4. BD
  5. Novo Nordisk A/S
  6. Boston Scientific Corporation
  7. Bausch Health Companies Inc.
  8. Baxter
  9. Boehringer Ingelheim
  10. Novartis AG
  11. GlaxoSmithKline plc.
  12. Johnson & Johnson Services, Inc.

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the drug delivery systems market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific drug delivery systems market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution